December 17, 2025 05:16 pm (IST)
Follow us:
Dahej plant of Torrent Pharma receives USFDA approval
Ahmedabad/Mumbai, Mar 18 (IBNS) Torrent Pharma, a leading Indian pharma company, informed on Friday that it has obtained the Establishment Inspection Report from the U.S. Food and Drug Administration (USFDA) for its plant located at Dahej SEZ, Gujarat.
The company had set up the plant mainly to cater to the regulated international markets such as US, Germany, Brazil, etc.
Prior to the US approval, the plant had received approval from EU Germany.
The Dahej plant is spread across 70 acres of land with a built up area of about 97000 sq meter. Phase 1 has an installed capacity to manufacture 7,500 million tablets/capsules and 25 MT API per annum.
The company has said that construction of Phase 2 will commence soon. After commission, the total capacity will increase to manufacture of 14,000 million tablets/capsules and 80 MT API per annum.
In their filing with the National Stock Exchang, the company has said that with the approval of the Dahej plant, three of its five plants have received USFDA approval.
The other two plants are located at Indrad (Gujarat) and Pithampur, Indore (Madhya Pradesh).
The company's share price moved up during trading hours on Friday following the news of the approval
Torrent Pharma is a flagship company of the Torrent Group.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
SBI rolls out YONO 2.0! Banking gets a major digital upgrade
Wed, Dec 17 2025
Nephrocare IPO pops on debut, dialysis major lists at 7% premium
Wed, Dec 17 2025
Rupee hits new lifetime low, but top economist says ‘don’t panic’
Wed, Dec 17 2025
How AI will reshape India: TCS and CII drop their report
Tue, Dec 16 2025
Why Gold Loans Are a Better Option than Selling Your Gold?
Tue, Dec 16 2025